Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. More Details
CLV passed our risk checks.
Solid track record with excellent balance sheet.
Share Price & News
How has Clover's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CLV is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: CLV's weekly volatility (8%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: CLV underperformed the Australian Chemicals industry which returned -29.1% over the past year.
Return vs Market: CLV underperformed the Australian Market which returned -1.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Clover's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 days ago | Simply Wall StIs Clover Corporation Limited (ASX:CLV) Popular Amongst Institutions?
2 weeks ago | Simply Wall StKey Things To Understand About Clover's (ASX:CLV) CEO Pay Cheque
Is Clover undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CLV (A$1.92) is trading above our estimate of fair value (A$0.87)
Significantly Below Fair Value: CLV is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CLV is good value based on its PE Ratio (25.6x) compared to the AU Chemicals industry average (32x).
PE vs Market: CLV is poor value based on its PE Ratio (25.6x) compared to the Australian market (22.4x).
Price to Earnings Growth Ratio
PEG Ratio: CLV is poor value based on its PEG Ratio (1.6x)
Price to Book Ratio
PB vs Industry: CLV is overvalued based on its PB Ratio (5.5x) compared to the AU Chemicals industry average (3.6x).
How is Clover forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLV's forecast earnings growth (15.7% per year) is above the savings rate (2.3%).
Earnings vs Market: CLV's earnings (15.7% per year) are forecast to grow slower than the Australian market (17.9% per year).
High Growth Earnings: CLV's earnings are forecast to grow, but not significantly.
Revenue vs Market: CLV's revenue (10.8% per year) is forecast to grow faster than the Australian market (5.1% per year).
High Growth Revenue: CLV's revenue (10.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLV's Return on Equity is forecast to be high in 3 years time (21.3%)
How has Clover performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CLV has high quality earnings.
Growing Profit Margin: CLV's current net profit margins (14.1%) are higher than last year (13.2%).
Past Earnings Growth Analysis
Earnings Trend: CLV's earnings have grown significantly by 45.3% per year over the past 5 years.
Accelerating Growth: CLV's earnings growth over the past year (23.6%) is below its 5-year average (45.3% per year).
Earnings vs Industry: CLV earnings growth over the past year (23.6%) exceeded the Chemicals industry -4.5%.
Return on Equity
High ROE: CLV's Return on Equity (21.7%) is considered high.
How is Clover's financial position?
Financial Position Analysis
Short Term Liabilities: CLV's short term assets (A$59.1M) exceed its short term liabilities (A$10.9M).
Long Term Liabilities: CLV's short term assets (A$59.1M) exceed its long term liabilities (A$13.0M).
Debt to Equity History and Analysis
Debt Level: CLV's debt to equity ratio (25.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if CLV's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: CLV's debt is well covered by operating cash flow (45.9%).
Interest Coverage: CLV's interest payments on its debt are well covered by EBIT (31.3x coverage).
What is Clover current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CLV's dividend (1.3%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.14%).
High Dividend: CLV's dividend (1.3%) is low compared to the top 25% of dividend payers in the Australian market (5.1%).
Stability and Growth of Payments
Stable Dividend: CLV's dividend payments have been volatile in the past 10 years.
Growing Dividend: CLV's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (33.3%), CLV's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CLV's dividends in 3 years are forecast to be well covered by earnings (42% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Peter J. Davey, MBA, GradDip Bus., Dip.Art(Design), GAICD, has been Chief Executive Officer and Managing Director of Clover Corporation Limited since November 11, 2014. Mr. Davey has held senior manage...
CEO Compensation Analysis
Compensation vs Market: Peter's total compensation ($USD696.06K) is above average for companies of similar size in the Australian market ($USD529.04K).
Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.
|CEO, MD & Director||6yrs||AU$951.52k||0.13% |
|Independent Chairman||3.17yrs||AU$125.51k||0.32% |
|Independent Non-Executive Director||3.75yrs||AU$70.82k||0.036% |
|Independent Non-Executive Director||7.5yrs||AU$76.24k||0.030% |
|Non-Executive Director||0.083yr||no data||0.010% |
|Non-Executive Director||0.083yr||no data||0.0071% |
Experienced Board: CLV's board of directors are considered experienced (3.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CLV insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Clover Corporation Limited's company bio, employee growth, exchange listings and data sources
- Name: Clover Corporation Limited
- Ticker: CLV
- Exchange: ASX
- Founded: 1988
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: AU$319.315m
- Shares outstanding: 166.31m
- Website: https://www.clovercorp.com.au
Number of Employees
- Clover Corporation Limited
- 39 Pinnacle Road
- Altona North
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CLV||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Nov 1999|
|CLV||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Nov 1999|
Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. The company is also involved in the production of encapsulated powders; and research and...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/11/23 10:41|
|End of Day Share Price||2020/11/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.